Latest News in the pharma Industry
Market News
Diversification and addition of capabilities key to CDMO success as end markets grow: CPhI North America panel
29 Jul 2021
CDMOs need to diversify and expand their capabilities to take full advantage of strong growth in prominent end markets such as small molecule, monoclonal antibodies and cell and gene therapy, according to an industry expert on a panel at the CPhI North...
Read more
UPDATED: COVID-19 Pharma Development Tracker
28 Jul 2021
The latest coronavirus updates and developments impacting the global pharmaceutical supply chain
Read more
Thermo Fisher pledges to reach carbon neutrality by 2050
27 Jul 2021
Accelerated efforts align with the Paris Agreement and Race To Zero to combat climate change
Read more
Abzena and BioXpress Therapeutics partner to provide global biosimilar support
27 Jul 2021
The combined capabilities will offer flexibility and innovation from small-scale biosimilar development through to large-scale manufacturing
Read more
Merck KGaA invests €270 million to create "site of the future"
21 Jul 2021
The investment will fund the construction of a Translational Science Center for its Healthcare business sector, as well as a new Learning Center
Read more
BioNTech to purchase Kite manufacturing facility and cell therapy R&D platform
21 Jul 2021
The acquisition will add manufacturing footprint in the US enabling the company to develop its pipeline of novel cancer product candidates
Read more
Samsung Biologics and Kineta strike cancer immunotherapy development and manufacturing deal
21 Jul 2021
Samsung to provide end-to-end CDMO services to advance Kineta's novel anti-VISTA antibody for the treatment of solid tumours
Read more
Skyepharma selects Veratrak platform to ensure secure data storing and sharing
20 Jul 2021
Using Veratrak's platform, the CDMO will have full oversight of data, including an audit trail of data and document processes
Read more
Curia to buy fellow CDMO Integrity Bio
14 Jul 2021
Acquisition will add West Coast coverage to the CDMO's East Coast and European capabilities and enhance its biologics formulation development and fill-finish network
Read more
Catalent enters CBD anaesthetic product formulation project
16 Jul 2021
The company will use its orally disintegrating tablet technology Zydis for JOS Pharmaceuticals' licensed CBD product
Read more
Sparx Therapeutics to build first commercial antibody drug production facility in China
14 Jul 2021
The emerging biotech company unveils plans for a 1.2 million-sq. ft manufacturing facility in Yangzhou
Read more
Sinovac Biotech signs up to supply COVAX with CoronaVac
14 Jul 2021
China-based company could supply up to 380 million doses from July 2021 through to June 2022
Read more